IBM (NYSE: IBM) stock used to be the darling of Wall Street. For most of our grandparents and even some of our parents, IBM was a staple stock in their portfolio. You could always count on Big Blue t...
In this week’s edition of Market Week in Review, Rob Cittadini, regional director, consultant relations, interviewed Mark Eibel, director, client investment strategies, on the latest round of geopol...
Last week, I noted: “I have a sneaky suspicion that when I update the Fed Balance Sheet reinvestment analysis next week, shown below, we are going to find a substantial, well-timed, reinvestment by ...
In early August, we observed that the US Dollar index was on the verge of a meaningful breakdown. Our technical analysis suggested that a weekly close below the congestion support level in the 93 area...
The economic reports of the last two weeks were not as bad as the market moves they precipitated. That could be due to other factors such as Hurricane Harvey and its impact on the energy industry or t...
Industrial component wholesaler W.W. Grainger (GWW), with 46 consecutive years of rising dividends, is one of the venerable dividend aristocrats. Even more impressive is that Grainger has rewarded l...
Earlier this year I wrote a post titled, “Insuring Your Portfolio With Insurance Stocks,” as I discussed the relatively boring nature of the industry, specifically the property and casualty insura...
With Hurricane Irma set to wreck havoc on Southern states in the U.S., USD/JPY broke through 108. No U.S. economic reports were released on Friday but the greenback has been tracking 10 year Treasury ...
It seemed like just a matter of time before an ETF such as this hit the marketplace. There are ETFs that allow you to invest in drone technology, whiskey producers, video games and Catholic value...
Deals and Financings OrbiMed, a global healthcare investor, closed its third Asia private equity fund with $551 million in capital commitments, about $100 million more than the target listed in its ...